Excerpt: PHILADELPHIA — For pregnant women, an influenza vaccination leads to bigger babies and infants who are less likely to get the flu, according to three studies presented here.

Experts said the findings — presented at the annual meeting of the Infectious Diseases Society of America — might help persuade pregnant women reluctant to get a flu shot.

It might also bring the issue to the attention of obstetricians, who typically do not raise the notion of a flu shot with their patients, said William Schaffner, MD, of Vanderbilt University Medical Center in Nashville.

Pregnant women do not need mercury injected into their bodies. Learn the truth in the  book  “The AutoImmune Epidemic “ by Donna Jackson Nakazawa who twice suffered  total body paralysis following  flu shots  ( Guillian Barre)  and who now points out that there are serious genetic changes  in our population so that one size fits all medicine is dangerous .

Dr Sherri Tenpenny, who has gathered more information on vaccines than almost anyone alive, has prepared some useful information for you to hand out to patients if you should choose.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Hello Everyone,
I put the following information together to help all pregnant women know the Truth about the Flu Shot for pregnancy.

A pdf will also be posted on www.drtenpenny.com so you can print this for family, friends and patients.

Best regards,
Dr Sherri Tenpenny
www.DrTenpenny.com

The Truth about Flu Shots in Pregnancy
Ø  Recommendations for vaccinating pregnant women are new:
•         2004: The Advisory Committee on Immunization Practice (ACIP) of the CDC began recommending vaccination in all pregnant women regardless of trimester. By vaccinating everyone, researchers estimated that an average of 1 or 2 hospitalizations could be prevented for every 1,000 pregnant women vaccinated.
o    REF: MMWR: May 28, 2004 / 53(RR06);1-40.
•         2009:  There is insufficient evidence to recommend routine flu shots as the standard of practice for healthy women beginning in early pregnancy.
o   REF: Skowronski  DM, De Serres G.  Is routine influenza immunization warranted in early pregnancy? Vaccine. Jul 30;27(35):4754-70. 2009.

Ø Pregnant woman are not frequently hospitalized for flu:
•         1998: Hospitalization ranged from 3.1 per 10,000 women-months in the first trimester to 10.5 per 10,000 in the third trimester.
o    REF: Neuzil KM, et al. Impact of influenza on acute cardiopulmonary   hospitalizations in pregnant women.  Am J Epidemiol 1998;148:1094-1102.
•         2004: Women in the third trimester were hospitalized at a rate (250/100,000 pregnant women), a rate comparable to non-pregnant women who had high-risk medical conditions. Consider that malpractice liability may play a role in the decision to admit third trimester women to the hospital.
o   REF: MMWR: May 28, 2004 / 53(RR06);1-40.
•         2009: The numbers of pregnant women hospitalized with pandemic H1N1 infection are small. Pregnant cases represented 34 of 5,469 H1N1 cases diagnosed during a four month study.
o    REF: Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. Aug 8;374(9688):451-8. 2009.

Ø  Vaccinating pregnant women has not reduced hospitalizations.
•         1997-2002:  A study of 49,585 pregnant women there was no statistically significant difference in rates of illness among vaccinated vs. unvaccinated women (4.5/10,000 vs.4.4/10,000). There were only two admissions per season for pneumonia.
o    REF: Black SB, et al. Effectiveness of the influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 21:333-339. 2004.

Ø  Pregnant women are generally as healthy as non-pregnant women.
•         1997-2002:  A study of 49,585 pregnant women, only 4.7% had outpatient visits for influenza-like illness.
o    REF: Black SB, et al. Effectiveness of the influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 21:333-339. 2004.
•         2009: Symptoms of H1N1 influenza infection are similar in both pregnant and non-pregnant general population except some pregnant women have more shortness of breath.
o    REF: Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. Aug 8;374(9688):451-8. 2009.

Ø Careful examination of the numbers used to mass vaccinate pregnant women reveals:
•         H1N1 occurs infrequently in pregnant women: 34 cases among an estimated 3,392,000 pregnant women in the U.S.
•         Among the 5,469 confirmed cases in the study, 0.62% were in pregnant women (34/5,469)
•         Claims that hospital admissions among pregnant women are much higher than in the general population are based on the use of numbers that accentuate the effect  (11/34 vs. 229/5,469).
•         The admission rate for pregnant women was 0.32 per 100, 000 and the estimated admission rate in the general population was 0.076 per 100 000. Hence the statement, “Pregnant women were more than four times more likely to be admitted than was the general population.”
o    REF: Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. Aug 8;374(9688):451-8. 2009.

Ø Both seasonal flu shots and 2009 H1N1 flu shots are labeled “Pregnancy Category C” drugs, meaning:
•         Animal reproduction studies have not been conducted.
•         It is not known whether influenza vaccines can cause harm to the fetus.
•         It is not know whether influenza vaccines can affect reproduction capacity.
•         It is not known whether influenza viruses from vaccines are excreted in human milk.
o    REF: From a review of all manufacturer package inserts

Ø Are anti-viral drugs safe to take while pregnant?
•         Both Tamiflu (oseltamivir) and Relenza (zanamivir) are classified as “Pregnancy Category C” drugs, meaning, there is insufficient information to assess potential risks to the fetus.
•         In lactating rats, Tamiflu was excreted in the milk. It is not known whether Tamiflu is excreted in human milk.
o    REF: From the package inserts

Info complied by Dr. Sherri Tenpenny at www.DrTenpenny.com

www.PandemicFluOnline.com www.MedicalVoices.org

This is very interesting research that would cause you to want to take exposure to flu more seriously!  First, let’s stay healthy so we do not get flu or colds with all that I discuss from Immuni-T 2 and 3 to long term detoxification, as in FIGHT program. Then since for many that is too rigorous a requirement, so let’s have an EMERGENCY SUPPORT PACKAGE in the homes of anyone that realizes who important this new research is!  Have BioE’nR-G’y C, ACS 200, and high dose D AND A available to immediately begin at the first sign of active infections.

What if their vaccines turn out to be as wrong for stopping H1N1, as MMR has been shown to be for compromised children? After MMR in autistic kids the live virus from the vaccination later has been shown to be growing in the CSF of these children.  Will the current testing of the new swine flu vaccines even attempt to look for how many receiving the vaccines actually wind up being infected with the virus instead of being protected against the virus, as they are not able to launch an immune response to the vaccine?

It appears that the virus accesses the neuron through the axons in the GI tract and lung. This sets the stage then for loss of Dopamine secreting cells over time.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Recent studies have suggested that the currently circulating strain of avian influenza has similar pathology to the 1918 flu. Though the subtypes of the viruses are different (Spanish flu shares the H1N1 subtype with the current H1N1 swine flu, whereas avian influenza has an H5N1 subtype), both viruses appear to enter the central nervous system (CNS) and can cause encephalitis, or inflammation of the brain.

Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
http://www.pnas.org/content/early/2009/08/07/0900096106.abstract

1.       Haeman Janga,b,
2.       David Boltzc,
3.       Katharine Sturm-Ramirezc,1,
4.       Kennie R. Shepherda,2,
5.       Yun Jiaoa,
6.       Robert Websterc and
7.       Richard J. Smeynea,3

+Author Affiliations
1.       Departments of aDevelopmental Neurobiology and
2.       cInfectious Diseases/Virology, St. Jude Children’s Research Hospital,
262 Danny Thomas Place, Memphis, TN 38105-3678; and
3.       bIntegrated Program in Biomedical Sciences, University of Tennessee
Health Science Center, Memphis, TN 38163
1.      1Present address: Fogarty International Center, National Institutes
of   Health, 16 Center Drive, Room 202, Bethesda, MD 20892.
2.      2Present address: Department of Environmental and Occupational
Health, Rollins School of Public Health and Center for
neurodegenerative Disease, Emory University, Whitehead Biomedical
Research Building, 5th Floor, Room 575.1, Atlanta, GA, 30322.

Abstract
One of the greatest influenza pandemic threats at this time is posed by the highly pathogenic H5N1 avian influenza viruses. To date, 61% of the 433 known human cases of H5N1 infection have proved fatal. Animals infected by H5N1 viruses have demonstrated acute neurological signs ranging from mild encephalitis to motor disturbances to coma. However, no studies have examined the longer-term neurologic consequences of H5N1 infection among surviving hosts. Using the C57BL/6J mouse, a mouse strain that can be infected by the A/Vietnam/1203/04 H5N1 virus without adaptation, we show that this virus travels from the peripheral nervous system into the CNS to higher levels of the neuroaxis. In regions infected by H5N1 virus, we observe activation of microglia and alpha-synuclein phosphorylation and aggregation that persists long after resolution of the infection. We also observe a significant loss of dopaminergic neurons in the substantia nigra pars compacta 60 days after infection. Our results suggest that a pandemic H5N1 pathogen, or other neurotropic influenza virus, could initiate CNS dis

You can now keep up to date on H1N1 from the leading
science publications. They are free and you can download the articles.

Be the expert on all this and know the facts, as we educate our patients about the facts, which will not be popular with many so called experts who are out to push their own agenda. Go to this link and check again every 2 weeks, as it will be constantly updated. http://www.thelancet.com/H1N1-flu

Be armed with facts that will counter the sales pitch the government
must offer to get rid of the over $1 billion of useless toxic swine flu
vaccines they have purchased sight unseen!!

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
August 18, 2009
Target journal: The Medical Journal of Australia

Vitamin D may reduce the risk of incidence and death from the current A/H1N1 “swine flu” pandemic

The current worldwide pandemic of A/H1N1 influenza “swine flu” has the potential to cause the infection and death of many people. This virus appears to have some seasonality, in common with epidemic influenza. There is good evidence that epidemic influenza is seasonal due to annual variations in solar ultraviolet-B (UVB) irradiance and vitamin D production.
1 The beneficial role of vitamin D is thought to be induction of human cathelicidin, LL-37, which has antimicrobial and antiendotoxin effects and, thus, seems to explain the reduced risk of infection of epidemic influenza. However, vitamin D did not seem to reduce the risk of infection during the 1918-19 pandemic A/H1N1 influenza. However, there is evidence from an ecological study that solar UVB and vitamin D reduced case-fatality rates after infection by that virus: case-fatality rates were much lower in southern United States cities than in northern cities.2 The mechanisms are thought to be suppression of the cytokine storm and reduced risk of bacterial pneumonia due to LL-37 induction. There is growing evidence that the current A/H1N1 influenza virus can be considered seasonal, with higher rates in winter. In addition, it has been reported that Australian Aborigines have much higher rates of respiratory infectious than European-Australians.3 Aborigines also have very low serum 25-hydroxyvitamin D levels,4,5 due to dark skin and indoor lifestyles. Thus, it would be useful to do a study in Australia of serum 25-hydroxyvitamin D levels of those who become infected with or die from swine flu. In addition, it would be worthwhile to recommend that people take vitamin D supplements especially in winter at doses of 1000-4000 IU/day in order to reduce the risk of respiratory infections including influenza. There are many other health benefits of vitamin D and very few risks.

Disclosure
I receive funding from the UV Foundation (McLean, VA), the Vitamin D Society (Canada), and the European Sunlight Association (Brussels).

References
1. Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol J. 2008;5:29.

2. Grant WB, Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermato-Endocrinology. 2009;1(4), epub.

3. Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet. 2009;374:65-75.

4. Nowson CA, Margerison C. Vitamin D intake and vitamin D status of Australians. Med J Aust. 2002;177:149-52.

5. Benson J, Wilson A, Stocks N, Moulding N. Muscle pain as an indicator of vitamin D deficiency in an urban Australian Aboriginal population. Med J Aust. 2006;185:76-7.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

August 6, 2009
Target journal: The Medical Journal of Australia

H1N1 2009 influenza virus infection during pregnancy is likely linked to low vitamin D status

The recent paper reporting that pregnancy women in 13 states had four times the risk of hospital admission for pandemic H1N1 2009 influenza virus than the general population1 represents a serious public health problem. While giving priority for H1N1 influenza vaccine to pregnant women and prompt treatment of such infected women is certainly indicated, it is also important to understand why pregnant women are more susceptible to this virus. It was hypothesized that epidemic influenza is largely seasonal is due to the annual variation in solar ultraviolet-B (UVB) doses and vitamin D production.2 That the infected women had a high case-fatality rate (19%), had a high fraction with Hispanic heritage, often developed pneumonia and required cesarean section delivery are also consistent with vitamin D deficiency. Case-fatality rates in the United States during the 1918-1919 influenza pandemic were generally due to subsequent pneumonia and were much higher in northern cities than in southern states, which was attributed to differences in solar UVB doses.3 Low vitamin D is also a significant risk factor for primary cesarean section delivery.4 It has been suggested that pregnant and nursing women require 4000-6000 IU/day of vitamin D,5 which is higher than 2000-4000 IU/day now considered required for the general population based on emerging scientific findings. There are many health benefits of vitamin D, so increasing vitamin D production would have many health benefits.

Disclosure
I receive funding from the UV Foundation (McLean, VA), the Vitamin D Society (Canada), and the European Sunlight Association (Brussels).

References
1. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 Jul 28. [Epub ahead of print]

2. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129-40.

3. Grant WB, Giovannucci D. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermato-Endocrinology 2009;1(4) epub

4. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94:940-5.

5. Hollis BW. Vitamin D requirement during pregnancy and lactation. J Bone Miner Res. 2007;22 Suppl 2:V39-44.

(Above articles and references submitted by)
William B. Grant, Ph.D.
Sunlight, Nutrition, and Health Research Center (SUNARC)
www.sunarc.org
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

1:30 PM PST, Wednesday, September 16, 2009
Dear Doctor,
Thanks for your update about the hospital in Wisconsin. I have had similar anecdotal evidence from my medical practice here in Georgia. We are one of the 5 states with widespread H1N1 outbreaks.
I share an office with another family physician. I aggressively measure and replete vitamin D. He does not.
He is seeing one to 10 cases per week of influenza-like illness.
In my practice– I have had zero cases. My patients are universally on 2000-5000 IU to maintain serum levels 50-80 ng/ml.
Sincerely,
(Letter from Family Health Practioner in Georgia)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Dear Doctor,
That’s good news. Now, if we just had a way for the CDC and the NIH to pay attention.
Critics say we should not recommend vitamin D to prevent influenza until it is proven to do so (It has not been).

The critics are thus saying, although they seem not to know it, you should be vitamin D deficient this winter until science proves being vitamin D sufficient is better than being Vitamin D deficient. Such advice is clearly unethical and has never ever been the standard of care.

This is not rocket science. If I am wrong, and Vitamin D does not prevent influenza, what is lost? A few dollars. If they are wrong, and it does prevent influenza, what is lost? So far, the CDC says 41 kids are dead from H1N1, and the flu season has not yet started.

Please contact your senators and congresspersons. Ask them to have hearings on vitamin D and H1N1:
http://www.usa.gov/Contact/Elected.shtml
Regards,
(Response from fellow practitioner in Washington state)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

The show will be a roundtable discussion primarily about the H1N1 virus and vaccines. The participants will include myself, Dr. Sherri Tenpenny & Dr. Lawrence Palevsky.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Beginning in August, the federal health agency is holding day-long public meetings at 10 sites in the nation. About 1,000 citizens will take part in the intensive meetings. Registration is open to everyone. (http://www.keystone.org/H1N1)

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
From: Mayer Eisenstein M.D. J.D. M.P.H.

CDC Asks Public to Help  on  Swine Flu Vaccine Call!!!
Citizens Asked to Help CDC With H1N1 Swine Flu Vaccine Decision

Should the nation rush to get a swine flu vaccine as soon as possible or wait until all safety questions are answered?
The CDC is asking for public discussion, deliberation and input as the agency considers whether to simply make vaccines available to those seeking immunization, to promote vaccination to those most at risk or to implement a widespread immunization program.
Beginning in August, the federal health agency is holding day-long public meetings at 10 sites in the nation. About 1,000 citizens will take part in the intensive meetings. Registration is open to everyone.

CDC spokesman Tom Skinner, “These are public engagement outreaches which involve meeting with a group of members of the public…  We’re trying to have an opportunity for public input into some of the decisions we are struggling with…
There are uncertainties that remain about how widespread and severe flu will be and how much demand there will be at the time for a vaccine…  Because of the complexities of planning, these uncertainties pose a difficult dilemma. Should the U.S. go full throttle, take a go-slow approach, or somewhere in between?”

Dr. Eisenstein’s Comments:
Has the CDC been listening to the Vaccine Webinars? Or maybe they have come to their senses, let the public decide if they want to take the swine flu vaccine.
Give the right to make medical decisions back to the Patients and their Doctors!  The notion of mandating an unsubstantiated injection with no clear evidence of efficacy is outrageous.
But the Swine flu vaccine is only a start.  I want the public to be able decide on every single vaccine that is being mandated. I have greater faith in the public’s decision than I do with the CDC, FDA, AMA, AAP or any other initial pseudoscientific medical organizations.
Vaccine choice is what it is all about. An informed and aware public both physically and intellectually is what is best for us.
We need Big Pharma and Big Government to stay out of our lives.
Flu vaccines have never worked in any age group. There is  limited or no data on the safety and effectiveness of the swine flu vaccine especially with the new untested  adjuvants.(formulated compounds, which when combined with vaccine antigens intensify the body’s immune response)

My recommendations:

1. Stay as far away from this swine flu vaccine experiment as possible. Flu vaccines have never worked.
2. Maintain adequate levels of Vitamin D and Probiotics.
3. Death from flu usually comes from a secondary pneumonia not from the flu itself. You must stay away from all over the counter and prescription Acid Reducing Pharmaceuticals Tums®, Rolaids®, Zantac®, Tagamet®, or the more dangerous, PPIs [Proton Pump Inhibitors] (Nexium®, Prevacid®, Prilosec®, Protonics®, etc..
4. And of course have lots of chicken soup available.